Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Review ArticleTeaching Case Studies

Evaluation of a Case of Inflammatory Breast Cancer with 18F-FDG PET/CT

Zaid Al-Faham, Sayf Al-Katib, Ishmael Jaiyesimi and Sharukh Bhavnagri
Journal of Nuclear Medicine Technology December 2015, 43 (4) 289-291; DOI: https://doi.org/10.2967/jnmt.114.148494
Zaid Al-Faham
1Department of Diagnostic Radiology and Molecular Imaging, William Beaumont School of Medicine, Oakland University, Royal Oak, Michigan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sayf Al-Katib
1Department of Diagnostic Radiology and Molecular Imaging, William Beaumont School of Medicine, Oakland University, Royal Oak, Michigan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ishmael Jaiyesimi
2Department of Hematology and Oncology, William Beaumont School of Medicine, Oakland University, Royal Oak, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharukh Bhavnagri
1Department of Diagnostic Radiology and Molecular Imaging, William Beaumont School of Medicine, Oakland University, Royal Oak, Michigan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Inflammatory breast cancer is a rare and aggressive form of cancer characterized by dermal lymphatic invasion and tumor embolization resulting in erythema and edema. In many cases, by the time of diagnosis there is already distant metastasis. Mammography, sonography, CT, and MRI are usually performed for initial staging; however, PET/CT can also be used for initial staging as it offers additional diagnostic information.

  • inflammatory breast cancer
  • IBC
  • PET/CT

Inflammatory breast cancer (IBC) is the most aggressive form of locally advanced breast cancer. Fortunately, it is rare and composes only 1%–6% of breast cancer cases (1). Pathologically, this type of cancer demonstrates highly angiogenic properties, which account for its early metastasis. The imaging and physical examination findings of IBC mimic those of inflammatory processes, and it is important to distinguish between these etiologies in a timely manner for proper management. Approximately 30% of women have stage IV de novo disease at diagnosis, and PET/CT has high sensitivity in identifying the extent of disease (2).

In this case report, we present the imaging findings of IBC on PET/CT with MRI correlation. We discuss the role of PET/CT in the workup and management of IBC, including diagnosis, staging, and prediction of overall survival in patients undergoing chemotherapy.

CASE REPORT

A 67-y-old woman presented after an area of erythema in her right axillary region had progressed to involve her right breast. Examination revealed diffuse erythema and edema of the right breast. A mammogram performed 1 y previously had shown no evidence of malignancy. Skin punch biopsy was performed and yielded invasive carcinoma compatible with IBC.

The patient subsequently underwent T2-weighted, maximum-intensity-projection, contrast-enhanced breast MRI, which showed asymmetric skin thickening of the right breast, breast distortion, and breast retraction (Fig. 1A). Increased T2 signal within the thickened skin was indicative of edema. A large, irregular parenchymal mass with peritumoral edema and spiculated margins was also noted in the central right breast. Subtracted postcontrast imaging demonstrated enhancement of the mass (Fig. 1B) and right axillary lymphadenopathy (Fig. 1C). Additionally, the overlying skin showed abnormal contrast enhancement due to involvement with malignancy.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

(A) T2-weighted MR image showing diffuse asymmetric skin thickening of medial right breast, breast distortion, breast retraction, and increased signal (arrow) within the thickened skin, compatible with edema. (B) Postcontrast MR image showing enhancement of skin (arrowhead) and of irregular breast parenchymal mass (arrow). (C) Subtracted postcontrast MR image showing abnormal enlarged right axillary lymph node (arrow).

PET/CT for initial staging was then performed. Sixty minutes after intravenous administration of 7.05 Bq (19.06 mCi) of 18F-FDG, sequential unenhanced CT and then PET images were acquired. The images showed an infiltrating mass with increased radiotracer activity within the right breast and extending into the axilla; quantification showed a maximum SUV of 8.1 (Fig. 2). Diffuse hypermetabolic skin thickening of the right breast corresponded to the abnormal findings on MRI. Moreover, multiple regional and distant 18F-FDG–avid lymph nodes were discovered, including the right axillary nodes and an enlarged portocaval node (Fig. 3). These findings were consistent with IBC with regional and distant metastases. Percutaneous core biopsy confirmed the presence of metastasis to the portocaval node.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

PET/CT (top left), CT (bottom left), whole-body maximum-intensity-projection PET (top right), and axial PET (bottom right) images. Infiltrating mass with increased radiotracer activity within right breast extends into axilla.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Axial PET/CT (top) and CT (bottom) images of 18F-FDG–avid portocaval node.

DISCUSSION

IBC is the most aggressive form of breast cancer and has poorer survival than non-IBC tumors (3). Imaging plays an important role in cases of IBC to detect intraparenchymal breast lesions, nodal involvement, and distant metastasis (3). Mammography and sonography are the recommended imaging modalities in the initial workup of IBC. However, MRI is also used in many cases to provide additional sensitivity for detection of breast parenchymal lesions.

Although these imaging modalities provide excellent sensitivity for locoregional disease, additional imaging is required to establish the stage and extent of disease, which are critical for treatment planning. CT and bone scanning are still used for initial staging (3). However, the use of PET/CT in this setting is increasing.

The usual findings in patients with IBC are multiple hypermetabolic breast foci associated with hypermetabolic thickened skin (1). PET/CT has high sensitivity for detection of breast lesions, axillary nodal involvement, and distant metastasis. Yang et al. reported that PET/CT had a sensitivity of 96% for the detection of breast parenchymal lesions, 95% for axillary metastasis, and 100% for distant metastasis (4). Champion et al. showed that PET/CT performed better than contrast-enhanced CT in the evaluation of regional lymph nodes (sensitivity, 93% vs. 86%, and positive predictive value, 93% vs. 89%) (2). In our patient, PET/CT was equal to breast MRI for the detection of locoregional disease, as both modalities detected the breast parenchymal lesion and the skin and axillary nodal involvement. PET/CT may give false-negative results in cases of small lesions, particularly in the liver and lung parenchyma. Also, false-positive results may occur in cases of inflammation or infection (5). Ipsilateral axillary lymph node uptake due to extravasation or partial subcutaneous injection of the antecubital region has been reported, thus giving false-positive results in some cases.

Multiple studies have shown that PET/CT detects metastases that were not previously suspected. For example, Carkaci et al. reported that among 41 patients with IBC, 7 of the 20 cases of distant metastases were not suspected before PET/CT (6). In our case, the staging PET/CT led to the discovery of distant nodal involvement in the portocaval region. PET/CT specifically is useful in detection of internal mammary lymph node involvement, which is predictive of recurrence (3).

In addition, PET/CT is useful for monitoring the response to treatment and for detecting early recurrence. Patients undergoing chemotherapy for IBC who show an interval decrease in tumor metabolic activity have better overall survival; every 10% decrease in SUV translates into a 15% lower probability of death, and complete resolution of tumor 18F-FDG uptake translates into an 80% lower probability of death (6).

In summary, MRI is more precise than mammography, sonography, and PET/CT for detecting cancer in an inflamed breast (6). PET/CT is useful for local and regional lymph node staging before neoadjuvant chemotherapy, for guidance regarding the fields to be irradiated after mastectomy, and for detection of remote metastases (5).

CONCLUSION

We have presented a case of IBC in which PET/CT was equal to MRI in evaluation of locoregional disease yet additionally provided detection of distant metastasis. PET/CT plays an important role in the diagnosis, staging, and monitoring of disease in IBC patients. Given the high likelihood of distant metastasis in cases of IBC, accurate initial staging with PET/CT is crucial as it affects treatment planning and ultimately patient outcome.

DISCLOSURE

No potential conflict of interest relevant to this article was reported.

Acknowledgments

We give special thanks to Robert Ceruti, CNMT, from the IT Department for his help.

Footnotes

  • Published online Nov. 19, 2015.

REFERENCES

  1. 1.↵
    1. Alberini JL,
    2. Lerebours F,
    3. Wartski M,
    4. et al
    . 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer. 2009;115:5038–5047.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Champion L,
    2. Lerebours F,
    3. Cherel P,
    4. et al
    . 18F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer. Eur J Nucl Med Mol Imaging. 2013;40:1206–1213.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Dawood S,
    2. Merajver SD,
    3. Viens P,
    4. et al
    . International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22:515–523.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Yang WT,
    2. Le-Petross HT,
    3. Macapinlac H,
    4. et al
    . Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat. 2008;109:417–426.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. de Bazelaire C,
    2. Groheux D,
    3. Chapellier M,
    4. et al
    . Breast inflammation: indications for MRI and PET-CT. Diagn Interv Imaging. 2012;93:104–115.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Carkaci S,
    2. Sherman CT,
    3. Ozkan E,
    4. et al
    . 18F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging. 2013;40:1809–1816.
    OpenUrlCrossRefPubMed
  • Received for publication September 14, 2014.
  • Accepted for publication March 25, 2015.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 43 (4)
Journal of Nuclear Medicine Technology
Vol. 43, Issue 4
December 1, 2015
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of a Case of Inflammatory Breast Cancer with 18F-FDG PET/CT
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Evaluation of a Case of Inflammatory Breast Cancer with 18F-FDG PET/CT
Zaid Al-Faham, Sayf Al-Katib, Ishmael Jaiyesimi, Sharukh Bhavnagri
Journal of Nuclear Medicine Technology Dec 2015, 43 (4) 289-291; DOI: 10.2967/jnmt.114.148494

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of a Case of Inflammatory Breast Cancer with 18F-FDG PET/CT
Zaid Al-Faham, Sayf Al-Katib, Ishmael Jaiyesimi, Sharukh Bhavnagri
Journal of Nuclear Medicine Technology Dec 2015, 43 (4) 289-291; DOI: 10.2967/jnmt.114.148494
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • High-Sensitivity Troponin Elevation in a Young Woman with Typical Chest Pain: The Heart of the Matter
  • Pulmonary Adenocarcinoma Revealed by Parathyroid Scintigraphy: An Incidental Case to Remember
  • Prominent Right Ventricular Tracer Uptake: A Harbinger of Multivessel Coronary Artery Disease
Show more Teaching Case Studies

Similar Articles

Keywords

  • inflammatory breast cancer
  • IBC
  • PET/CT
SNMMI

© 2025 SNMMI

Powered by HighWire